Radar › Companies › Cardiac and Vascular Disorders · Central District
Radar · Cardiac and Vascular Disorders in Central District

Best Cardiac and Vascular Disorders Companies in Central District, Israel

The 30 best Cardiac and Vascular Disorders companies in Central District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CathWorks.

30companies tracked
$303.2Mdisclosed funding
0unicorns
15have raised

Ranked: Best Cardiac and Vascular Disorders companies in Central District

#CompanyDisclosed fundingLast roundStageEmployeesFoundedFounderPatents & IP focusRecent signals
1CathWorks
Developer of angiogram-based physiology measurement solution
$151M52 mo agoAcquired742013Ifat Lavi
Founder & CTO
178 patents
AI-driven analysis and visualization of coronary angiography and vascular lesion assessment
—
2Pi-Cardia
Developer of non-implant device for valve repair
$40M79 mo agoSeries D502009Erez Golan
Co-Founder & CEO
62 patents
Transcatheter heart valve cutting, laceration, and calcification removal devices
—
3OrSense
Provider of non-invasive sensing technology for body vitals measurement
$33M186 mo agoSeries B241996Yoav Reisman
CEO
60 patents
Non‑invasive optical blood analysis for point‑of‑care diagnostic monitoring
—
4Laminate Medical
Device to prevent AV Fistula failure by promoting their maturation and patency
$20M84 mo agoSeries C202012Eyal Orion
Co-Founder & Board Member
——
5Endoron Medical
Manufacturer of endovascular suture-like device for cardiovascular treatment
37Moat top 25%Patents top 31%Innovation top 33%Funding top 39%
All 7 signals ▾
Moattop 25%
Patentstop 31%
Innovationtop 33%
Fundingtop 39%
Talentbottom 49%
Globalbottom 43%
Marketbottom 28%
Moat: Editorial + unicorn rating 7/10 · IP moat: 38 patents
Patents: 38 patents matched (strict assignee match) · 30 filings since 2022 vs 8 in 2017-21
rank vs industry peers · Fliar Intelligence Index 37/100
$15M28 mo agoSeries A102019Ron Karmeli
Co-Founder & CMO
38 patents
Intravascular graft anchoring and catheter-based vascular closure devices
—
6Angioslide
Embolic capture device integrated with angioplasty balloon to prevent distal embolization
$15M166 mo agoSeries B122005—80 patents
Drug‑coated balloon catheters for targeted vascular drug delivery and angioplasty
—
7Kyma
Remote patient monitoring solutions for chronic cardiac patients
$10M157 mo agoAcqui-Hired112008Uriel Weinstein
Co-founder
——
8Ovalum Vascular
Solutions for chronic and acute total occlusions in the coronary and peripheral arteries.
$4M242 mo agoDeadpooled—2005Noam Shamay
Founder & CEO
——
9Bendit Technologies
Steerable & torque able microcatheter for better navigation
$4M109 mo agoSeries A232013—6 patents
Robotic catheter steering mechanisms for minimally invasive medical procedures.
—
10Oxitone
Wrist-based Pulse Oximetry health monitor
$3M138 mo agoSeed112010Leon Eisen
Founder & Executive Chairman
——
11Leviticus Cardio
Wireless power transfer system to cater the power needs of VAD Implants
$3M94 mo agoSeed72008—30 patents
Implantable cardiac device power management, hybrid energy, batteries, and patient monitoring systems.
—
12Nicast
Nano fabric biomaterials for vascular access & wound care
$3M136 mo agoDeadpooled111995Alex Dubson
Founder & CTO
86 patents
Patents concentrated in health & consumer products
—
13Eximo Medical
Hybrid catheters for vascular procedures
$2M135 mo agoAcquired152012—74 patents
Intravascular laser ablation and lesion characterization catheters for vascular interventions
—
14Biobeat
Body vitals monitoring solution
48Tech top 34%Growth top 35%Product top 40%Funding top 46%
All 7 signals ▾
Techtop 34%
Growthtop 35%
Producttop 40%
Fundingtop 46%
Moattop 48%
Globalbottom 38%
Marketbottom 37%
Tech: 38 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare
Growth: Fresh capital in last 24 mo
rank vs industry peers · Fliar Intelligence Index 48/100
$1M10 mo agoSeries B292014———
15VVT Medical
Percutaneous delivery of vascular embolic device for the treatment of varicose veins
37Product top 14%Growth top 35%Funding top 44%Patents top 45%
All 9 signals ▾
Producttop 14%
Growthtop 35%
Fundingtop 44%
Patentstop 45%
Moattop 45%
Innovationtop 47%
Techtop 48%
Globalbottom 37%
Marketbottom 24%
Product: 4 distinct product lines · Company stage: Post IPO
Growth: Fresh capital in last 24 mo
rank vs industry peers · Fliar Intelligence Index 37/100
$779K7 mo agoLate Stage112007—78 patents
Patents concentrated in health & consumer products
—
16Elfi-Tech
Developing technology for non-invasive physiological monitoring and diagnostics
$113K91 mo agoFunding Raised142006Ilya Fine
Founder & CEO
42 patents
Non‑invasive optical blood‑pressure and hemodynamic monitoring using dynamic light scattering
—

Top 12 Cardiac and Vascular Disorders companies in Central District

#1
Late Stage · Kfar Saba, Central District · founded 2007 · 11 employees
$779.2Kraised
▾

VVT Medical has developed a medical technology for the treatment of varicose veins. Its procedure called V-Block includes a percutaneous delivery of vascular embolic device (called v-block device) into the proximal great saphenous vein (GSV) and induce a concomitant liquid sclerotherapy using its proprietary dual procedure syringe system by the simultaneous aspiration of the blood and the discharging of the sclerosing agent. Claims that the procedure requires no anesthesia and requires minimal post procedure care.

Fliar Intelligence Index™ 37how this company ranks against its industry peers
Product
top 14%
Growth
top 35%
Funding
top 44%
Patents
top 45%
Moat
top 45%
Innovation
top 47%
Product: 4 distinct product lines · Company stage: Post IPO
Growth: Fresh capital in last 24 mo
Funding: Raised $779k across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Post IPO (Apr 2026)
Funding rounds
  • Apr 2026Post IPO$779.2K
Tech stack
CdnjsCloudflareCookiebotCore-JsDropzoneElementor
#2
Series B · Petah Tikva, Central District · founded 2014 · 29 employees
$1Mraised
▾

Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the user's data is stored. Data is then compared against a person's normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.

Fliar Intelligence Index™ 48how this company ranks against its industry peers
Tech
top 34%
Growth
top 35%
Product
top 40%
Funding
top 46%
Moat
top 48%
Global
bottom 38%
Tech: 38 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare · Observability: Microsoft Clarity
Growth: Fresh capital in last 24 mo
Product: 2 published apps (9.0k installs) · Company stage: Series B
Audience (LinkedIn): 19k LinkedIn followers — 32.9% of this cohort's audience
Activity (LinkedIn): 1 expansions announced in 12 mo
Funding rounds
  • Dec 2025Series B$50M
  • Oct 2019Grant (prize money)$188.5K
  • Jun 2016Angel$1M
Investors
Europa, Ally Bridge Group, Orbimed, Elevage Medical Technologies, Hangar 51, Florida-Israel Business Accelerator
Tech stack
Amazon Web ServicesCloudflareCloudflare Bot ManagementCore-JsElementorGoogle Analytics
#3
Series A · Kfar Saba, Central District · founded 2019 · 10 employees
$15Mraised
▾

Manufacturer of endovascular suture-like device for cardiovascular treatment. It uses a smart stapling mechanism that enables multiple staples to simultaneously penetrate the stent graft and the aortic wall. With a small profile delivery system, the device, Aortoseal is quickly deployed via a single release action. It enables the implementation of endograft procedures in almost all types of anatomies and can dramatically reduce complications and reinterventions.

Fliar Intelligence Index™ 37how this company ranks against its industry peers
Moat
top 25%
Patents
top 31%
Innovation
top 33%
Funding
top 39%
Talent
bottom 49%
Global
bottom 43%
Moat: Editorial + unicorn rating 7/10 · IP moat: 38 patents
Patents: 38 patents matched (strict assignee match) · 30 filings since 2022 vs 8 in 2017-21 · Latest publication 2026
Innovation: 38 patents (top 54% of patent-holders) · 30 filings since 2022 vs 8 in 2017-21 · Deep-tech classification: Tech Hardware
Audience (LinkedIn): 5k LinkedIn followers — 7.7% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Director / VP R&D – Structural Heart and Cardiovascular Devices
Funding rounds
  • Jul 2024Series A$10M
  • Feb 2023Grant (prize money)$2.7M
  • 2022Grant (prize money)$2.8M
  • Dec 2021Seed$5M
Founders & team
Ron KarmeliCo-Founder & CMO
Investors
Sofinnova Partners, EIC Fund, MD Start, MedTech Innovator
#4
Acquired · Kfar Saba, Central District · founded 2013 · 74 employees
$150.8Mraised
▾

CathWorks is developing FFRAngio, a novel technology for angiogram-based physiology measurement that does not require pressure wires or hyperemic stimulus. It is based on the processing of visual information and automatic multi-layered algorithms. Its technology is focused on improving the utilization of coronary angiography data to validate measurement-based medicine in the cath lab.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 21.0% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jul 2022Series E$75M
  • Jan 2021Series D$30M
  • Feb 2019Series C$30M
  • Oct 2017Series B$15.8M
Founders & team
Ifat LaviFounder & CTO
Investors
Medtronic, Deerfield, Quark Venture, Planven Investments, Pontifax, Corundum Open Innovation
Tech stack
Animate.CssCloudflareCloudflare Bot ManagementComplianzCore-JsGodaddy
#5
Series D · Rehovot, Central District · founded 2009 · 50 employees
$40Mraised
▾

Pi-cardia manufactures non-implant devices for valve repair. The product Leaflex provides lines that create separation between the calcium deposits on the two sides of the scoring line, in order to regain leaflets flexibility, allow their mobility and improve valve hemodynamics.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 23.8% of this cohort's audience
Activity: 1 partnerships (incl. Geisinger Danville Medical Center) announced in 12 mo
Funding rounds
  • Apr 2020Series D$27M
  • Dec 2018Series C$3M
  • Jan 2016Series C$10M
Founders & team
Erez GolanCo-Founder & CEOEyal KolkaCo-Founder
Investors
Innogest Capital, VI Ventures, Clal Biotechnology Industries, Sofinnova Partners, Accelmed, Indaco Venture Partners
Tech stack
BootstrapGodaddyGoogle CloudGoogle Cloud CdnGsapHsts
#6
Series C · Rehovot, Central District · founded 2012 · 20 employees
$20Mraised
▾

Laminate medical produces VasQ, a device designed to improve maturation and patency rates of AV fistulas. It provides external support thereby addressing the root causes of fistula failure. Failure is often due to clotting and thrombosis of the fistula which is caused by turbulent flow patterns around the anastomosis region, which VasQ prevents. Early failure occurs in over 40% of fistulas created using conventional techniques.The VasQ is not available in the US

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 5.0% of this cohort's audience
Activity: 2 partnerships (incl. Tapete' Medical Ltd.) announced in 12 mo
Funding rounds
  • Oct 2019Series C—
  • Jan 2019Series C$12M
  • Feb 2017Series B$8M
  • Mar 2016Grant (prize money)$56.6K
Founders & team
Eyal OrionCo-Founder & Board Member
Investors
Rad, Europa, ADIP, Talis Capital, Haisco Pharmaceutical Group, Asahi Kasei
Tech stack
Contact Form 7Core-JsGodaddyGoogle AnalyticsGoogle Font ApiGoogle Tag Manager
#7
Series B · Petah Tikva, Central District · founded 1996 · 24 employees
$33.2Mraised
▾

Provider of non-invasive sensing technology for body vitals measurement. The company develops and commercializes patient monitoring solutions for non-invasive continuous measurements of haemoglobin, oxygen saturation, glucose, and other blood parameters. Utilizing its proprietary Occlusion Spectroscopy technology, it also enables the monitoring of the oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram, and haemoglobin. The system is designed for use in hospitals in operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services.

Founders & team
Yoav ReismanCEO
Investors
Israel HealthCare Ventures, Star Ventures, moital, Tamar Ventures, Saints Capital
Tech stack
BluehostDiviEndurance Page CacheGoogle Font ApiJqueryJquery Migrate
#8
Series B · Netanya, Central District · founded 2005 · 12 employees
$14.6Mraised
▾

Angioslide has developed the Proteus device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Distal embolization is a common complication of interventions to treat PAD. Angioslide helps physicians to manage embolic load released during procedures . The device enables physicians to capture and remove embolic particles dislodged at the lesion site in peripheral arteries through the device's Proteus Embolic capture feature which is integrated with the balloon. PROTEUS embolic capture feature involves a single-use suction mechanism that works through inward folding of the balloon, which creates negative pressure within the capture cavity for debris capture and removal. The reduced pressure in the capture cavity causes some of the particles that are released during the procedure to flow into the cavity for containment and removal. Used during angioplasty procedures. Product is both FDA and CE cleared for use in the lower limbs i.e. the femoral, iliac, ilio-femoral, popliteal, tibial, peroneal and profunda arteries.

Funding rounds
  • Jan 2013Series B$6.3M
  • Oct 2009Series B$8.2M
Investors
Triventures, Viola Group, XT Hi-Tech, BioStar Capital, Agate, Ofer-Hi Tech
Tech stack
WordpressMysqlPhpBootstrapNginxJquery Migrate
#9
Acqui-Hired · Kfar Saba, Central District · founded 2008 · 11 employees
$10Mraised
▾

Kyma Medical Technologies develops patient monitoring solutions to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kyma’s solutions aim at providing healthcare professionals with accurate information on the patient's clinical status for support of medical decision-making. Kyma’s technology is currently applied via external use, and a subcutaneous approach is under development, thus meeting the needs of a variety of patient populations. The Kyma µ-Cor is CE Mark-approved for monitoring of one or more of the following clinical parameters: Thoracic Fluid Content, ECG, heart rate, respiratory rate, activity and body posture. As of November 2016, the device is not FDA approved and still under investigation in the US.

Funding rounds
  • Oct 2013Series A$10M
Founders & team
Uriel WeinsteinCo-founder
Investors
Ganot Capital, Rafael Development Corporation, Elron Ventures
#10
Deadpooled · Rehovot, Central District · founded 2005
$4.4Mraised
▾

Ovalum focuses on the development and implementation of effective and safe solutions for chronic and acute total occlusions in the coronary and peripheral arteries. Based on proprietary shape memory alloy techniques and unique knowledge of laser processes, Ovalum claims that its systems will revolutionize the fields of minimally-invasive cardiology and interventional radiology.

Funding rounds
  • Sep 2006Series A$3.4M
  • Dec 2005Seed$1M
Founders & team
Noam ShamayFounder & CEO
Investors
MediTech Advisors, Pontifax, Smithfield Trust, Ziegler Meditech Equity Partners
#11
Series A · Petah Tikva, Central District · founded 2013 · 23 employees
$3.5Mraised
▾

Bendit Technologies, a JV between Lev Dies, Li-Med & Ozca Engineering Solutions is focussed on providing solutions to interventional radiologists and neuroradiologists for their minimally invasive procedures, such as endovascular coiling or chemoembolization. It has developed a steerable 2.7Fr peripheral/visceral microcatheter so as to achieve optimal navigation results in small outer diameters. It claims that catheter helps to shape the tube in any direction with controlled steering abilities ±1° spheric degree.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 5.8% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Mechanical Engineer
Funding rounds
  • Oct 2017Series A$3.5M
Investors
Primer Capital, TechWald Holding, Indaco Venture Partners, MEDA Angels
#12
Seed · Petah Tikva, Central District · founded 2008 · 7 employees
$2.6Mraised
▾

Leviticus Cardio has developed wireless power transfer system capable of providing the day-to-day power needs of available Ventricular Assist Device(VAD) implants. VAD, an implanted mechanical circulatory pump, is connected to an external power pack by a drive line. Infection related to the drive line represents the single most important challenge to extended VAD use. Leviticus Cardio has developed a Wireless Coplanar Energy Transfer (CET) system that provides the power needs of available VAD implants while avoiding the complications from infection associated with technologies.

Funding rounds
  • Jan 2019Grant (prize money)—
  • Apr 2015Seed$1.5M
  • Oct 2013Seed$1.1M
Investors
BIRD Foundation, The Trendlines Group
Tech stack
PleskWindows ServerYoutubeMicrosoft Asp.NetIisGoogle Analytics

Funding & investor landscape

$303.2Mtotal disclosed funding
16companies funded
34disclosed rounds
0rounds last 90 days
Most active investors
EIC Fund6 rounds
Europa5 rounds
BioStar Capital3 rounds
Accelmed2 rounds
Asahi Kasei2 rounds
Indaco Venture Partners2 rounds
Kreos Capital2 rounds
Pontifax2 rounds
Saints Capital2 rounds
Sofinnova Partners2 rounds

Notable founders

Ron Karmeli
Co-Founder & CMO · Endoron Medical
Ifat Lavi
Founder & CTO · CathWorks
Erez Golan
Co-Founder & CEO · Pi-Cardia
Eyal Kolka
Co-Founder · Pi-Cardia
Eyal Orion
Co-Founder & Board Member · Laminate Medical
Yoav Reisman
CEO · OrSense
Uriel Weinstein
Co-founder · Kyma
Noam Shamay
Founder & CEO · Ovalum Vascular
Leon Eisen
Founder & Executive Chairman · Oxitone
Alex Dubson
Founder & CTO · Nicast
Hezy Aspis
CEO · Nicast
Ilya Fine
Founder & CEO · Elfi-Tech
Prism market signals · Israel · country-scoped Prism corpus, 1,228,971 docs

Market landscape — 10 sub-themes by coverage

Share of Cardiac and Vascular Disorders coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Cardiac and Vascular Disorders companies are there in Central District, Israel?
Radar tracks 30 indexable Cardiac and Vascular Disorders companies headquartered in Central District, Israel that meet our profile-completeness bar.
What is the total funding raised by Cardiac and Vascular Disorders companies in Central District, Israel?
The Cardiac and Vascular Disorders companies in Central District, Israel on this list have raised a combined $303.2M in disclosed equity funding across 16 funded companies.
Which is the highest-funded Cardiac and Vascular Disorders company in Central District, Israel?
CathWorks is the highest-funded Cardiac and Vascular Disorders company in Central District, Israel, with $150.8M in disclosed equity funding.
How many Cardiac and Vascular Disorders companies in Central District, Israel are funded?
16 of the 30 Cardiac and Vascular Disorders companies in Central District, Israel on this list have disclosed at least one equity funding round.
How many Cardiac and Vascular Disorders unicorns are there in Central District, Israel?
None of the Cardiac and Vascular Disorders companies in Central District, Israel on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Central District, Israel Cardiac and Vascular Disorders companies?
The most active investors in Central District, Israel Cardiac and Vascular Disorders companies on this list include EIC Fund, Europa, BioStar Capital, Accelmed, Asahi Kasei.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon